CollPlant Holdings Ltd.

CollPlant Holdings Ltd. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. CollPlant Holdings Ltd. is not a good value stock. CollPlant Holdings Ltd. is not a good growth stock. CollPlant Holdings Ltd. is a mediocre stock to choose.
Log in to see more information.
Collplant Holdings Ltd. is a regenerative medicine company. It engages in the research, development,...

News

HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.'s Q3 2024 Earnings (NASDAQ:CLGN)
HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.'s Q3 2024 Earnings (NASDAQ:CLGN)

Ticker Report CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Free Report) - HC Wainwright lifted their Q3 2024 earnings per share estimates for shares of CollPlant Biotechnologies in a report released on Wednesday...\n more…

Analysts Offer Predictions for CollPlant Biotechnologies Ltd.'s FY2027 Earnings (NASDAQ:CLGN)
Analysts Offer Predictions for CollPlant Biotechnologies Ltd.'s FY2027 Earnings (NASDAQ:CLGN)

Ticker Report CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Free Report) - Stock analysts at HC Wainwright lowered their FY2027 earnings per share (EPS) estimates for CollPlant Biotechnologies in a research note...\n more…

CollPlant Biotechnologies (NASDAQ:CLGN) Receives Buy Rating from HC Wainwright
CollPlant Biotechnologies (NASDAQ:CLGN) Receives Buy Rating from HC Wainwright

Ticker Report HC Wainwright reissued their buy rating on shares of CollPlant Biotechnologies (NASDAQ:CLGN - Free Report) in a research note published on Wednesday morning, Benzinga reports. They currently have a...\n more…

CollPlant, Stratasys Initiate Study for Breast Implants
CollPlant, Stratasys Initiate Study for Breast Implants

Benzinga CollPlant Biotechnologies (NASDAQ: CLGN) and Stratasys Ltd.\n more…

Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies

Benzinga Throughout the last three months, 4 analysts have evaluated CollPlant Biotechnologies CLGN, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.\n more…

CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript
CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript

Seeking Alpha - Israel Stocks CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript...\n more…